Evidence map›Paper›PMID 27686397›Full record

ReviewBiotechnology advances2016

Advances in nanomaterials and their applications in point of care (POC) devices for the diagnosis of infectious diseases.

Dai Thien Nhan Tram, Hao Wang, Sigit Sugiarto, Tao Li, Wee Han Ang, Chengkuo Lee, Giorgia Pastorin

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Biotechnology advances, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Betanodavirus and VER Disease: A 30-year Research Review.Pathogens (Basel, Switzerland) · 2020
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dai Thien Nhan TramPharmacy Department National University of Singapore, Singapore 117543, Singapore. Electronic address: tram.dai.thien.nhan@u.nus.edu.
Hao WangDepartment of Electrical and Computer Engineering, National University of Singapore, 4 Engineering, Drive 3, Singapore 117576, Singapore. Electronic address: elewangh@nus.edu.sg.
Sigit SugiartoDepartment of Chemistry, National University of Singapore, Singapore 117543, Singapore. Electronic address: sigit.sugiarto@u.nus.edu.
Tao LiDepartment of Chemistry, National University of Singapore, Singapore 117543, Singapore. Electronic address: litao@u.nus.edu.
Wee Han AngDepartment of Chemistry, National University of Singapore, Singapore 117543, Singapore. Electronic address: chmawh@nus.edu.sg.
Chengkuo LeeDepartment of Electrical and Computer Engineering, National University of Singapore, 4 Engineering, Drive 3, Singapore 117576, Singapore. Electronic address: elelc@nus.edu.sg.
Giorgia PastorinPharmacy Department National University of Singapore, Singapore 117543, Singapore; NanoCore, Faculty of Engineering, National University of Singapore, Singapore 117576, Singapore; NUS Graduate School for Integrative Sciences and Engineering, Centre for Life Sciences (CeLS), Singapore 117456, Singapore. Electronic address: phapg@nus.edu.sg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanotechnology has gained much attention over the last decades, as it offers unique opportunities for the advancement of the next generation of sensing tools. Point-of-care (POC) devices for the selective detection of biomolecules using engineered nanoparticles have become a main research thrust in the diagnostic field. This review presents an overview on how the POC-associated nanotechnology, currently applied for the identification of nucleic acids, proteins and antibodies, might be further exploited for the detection of infectious pathogens: although still premature, future integrations of nanoparticles with biological markers that target specific microorganisms will enable timely therapeutic intervention against life-threatening infectious diseases.

Indexed as

NanostructuresPoint-of-Care SystemsCommunicable DiseasesHumansNanomedicineDiagnostic toolsInfectious diseasesNanotechnologyPathogensPoint-of-care (POC)

Identifiers

PMID27686397
PMCPMC7127209

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.